Literature DB >> 1700738

Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.

S J Khoury1, O Lider, A al-Sabbagh, H L Weiner.   

Abstract

Oral administration of myelin basic protein (MBP) suppresses experimental autoimmune encephalomyelitis (EAE) in Lewis rats immunized with MBP in Freund's adjuvant. The immunomodulator bacterial lipopolysaccharide (LPS) when given orally in conjunction with MBP enhances the protective effects of MBP feeding in EAE. This synergy was achieved only following oral administration of LPS but not following subcutaneous injection. In contrast, subcutaneous administration of LPS abrogated oral tolerance. A synergism between oral LPS and MBP was also demonstrated for antigen-specific suppression of delayed type hypersensitivity (DTH) responses. Antibody responses to MBP were suppressed by oral administration of MBP but not by MBP plus LPS. The lipid A moeity of LPS mimicked the effects of LPS on disease protection and DTH suppression. These data demonstrate that adjuvants can enhance the induction of antigen-specific oral tolerance for suppression of cell-mediated experimental autoimmune responses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700738     DOI: 10.1016/0008-8749(90)90256-q

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  19 in total

1.  Preoperative mucosal tolerance to brain antigens and a neuroprotective immune response following surgical brain injury.

Authors:  Robert E Ayer; Nazanin Jafarian; Wanqiu Chen; Richard L Applegate; Austin R T Colohan; John H Zhang
Journal:  J Neurosurg       Date:  2011-10-21       Impact factor: 5.115

Review 2.  Oral tolerance and the treatment of rheumatoid arthritis.

Authors:  H L Weiner; Y Komagata
Journal:  Springer Semin Immunopathol       Date:  1998

Review 3.  Oral tolerance.

Authors:  W Strober; B Kelsall; T Marth
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

Review 4.  A T cell/B cell/epithelial cell internet for mucosal inflammation and immunity.

Authors:  K Fujihashi; M N Kweon; H Kiyono; J L VanCott; F W van Ginkel; M Yamamoto; J R McGhee
Journal:  Springer Semin Immunopathol       Date:  1997

Review 5.  Antigen-specific therapies for the treatment of autoimmune diseases.

Authors:  D A Hafler; H L Weiner
Journal:  Springer Semin Immunopathol       Date:  1995

Review 6.  Experimental autoimmune uveitis: molecular mimicry and oral tolerance.

Authors:  V K Singh; K Nagaraju
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

7.  Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.

Authors:  A Miller; O Lider; A B Roberts; M B Sporn; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

8.  Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity.

Authors:  L V Rizzo; N E Miller-Rivero; C C Chan; B Wiggert; R B Nussenblatt; R R Caspi
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

9.  Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.

Authors:  Z J Zhang; L Davidson; G Eisenbarth; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

Review 10.  Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis.

Authors:  Shailesh R Satpute; Malarvizhi Durai; Kamal D Moudgil
Journal:  Semin Arthritis Rheum       Date:  2008-01-04       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.